Objective To provide population-based estimates of the hospital-related costs of maternal and newborn care, and how these vary by gestational age and birth weight.
Conclusions Both maternal and neonatal costs are skewed, with this being much more pronounced for infants.
Preterm birth is much more expensive than term delivery, with the additional costs predominately incurred by the infants. The small share of infants who require extensive stays in neonatal intensive care incur a large share of neonatal costs and these costs have increased over time. (J Pediatr 2019; 204:118-25) . P regnancy and delivery are the most common reasons for the hospitalization of women of childbearing age, with almost 4 million deliveries annually in the US. 1 Peripartum and newborn infant care, particularly for the extremely premature infant, make up a substantial proportion of the costs of medical care for these patients, with estimates of the costs of preterm birth accounting for almost $26 billion annually. 2 Neonatal and maternal care has continued to evolve over time, including rising rates of cesarean deliveries and more aggressive management and resuscitation of infants born at periviable gestational ages (<24 weeks). [3] [4] [5] However, with decreases in mortality and more aggressive resuscitation come greater use of health care resources. Although preterm rates have been relatively constant, 6 ,7 the neonatal mortality rate has decreased, especially for very preterm infants. 4, 8, 9 The reduction in very preterm mortality is especially significant, given the very large cost and length of stay (LOS) differences between survivors and deaths. 10 There currently are few data to quantify the economic impact of these changes in both maternal and neonatal care. The existing studies using data linking mothers to infants and transfers to accurately measure the total costs of delivery are from 2000 or earlier, and thus fail to capture the effects of more recent changes in costs, technologies, and outcomes. 2, [10] [11] [12] More recent data tend to use hospital charges instead of costs or use unlinked discharge data that cannot measure the economic impact of mothers or infants across the multiple hospitals where they receive care before being discharged home. Because these women and infants tend to be the sickest and most expensive cases, such data may underestimate the impact of certain subgroups of patients. 13 Finally, previous data omit physician costs. The goal of this project was to provide population-based estimates of the costs and LOS for hospitalizations associated with childbirth, including pregnancyrelated maternal hospitalization and infant transfers before discharge home or death. We include both hospital costs, as performed in prior work, and updated methods to include an estimate of physician costs. Further, to provide policymakers and
BW

Birth weight ICD-9 International Classification of Diseases, 9th edition, Clinical Modification
LOS
Length of stay PPI Producer price index researchers with in-depth data useful for additional analyses, we provide data stratified by gestational age, birth weight (BW), and survival status.
Methods
We used the California Office of Statewide Planning and Development Vital Statistics-Patient Discharge Data to obtain a population-based study cohort of all in-hospital deliveries in that occurred in California nonfederal hospitals between 2009 and 2011. Maternal and infant hospital discharge records were probabilistically linked with birth, infant death, and fetal death certificates to provide linked information for mother-baby pairs. Approximately 96% of in-hospital birth records were successfully linked to maternal and infant hospital discharge abstract data. 14 Although these linkages are officially probabilistic, the vast majority are unique matches and most of the probabilistic linkages are for uncomplicated term infants for whom the nonexact linkages have minimal effect on the analyses conducted for this study. These data include maternal antepartum records for the 9 months before delivery. Infant hospital discharge records include the delivery admission and subsequent transfers until the infant was initially discharged to home or died. This study was approved by the Stanford University Institutional Review Board and the California Department of Health Services Committee for the Protection of Human Subjects.
Cases were selected if the birth certificate was successfully linked to both the maternal delivery record and the infant delivery record or if the fetal death certificate was linked to a maternal hospital record. Maternal prenatal hospitalization records were retained for pregnancy-related prenatal hospitalizations falling within the gestation period of the current pregnancy based on gestational age at birth (fetal death). Prenatal hospitalizations were considered pregnancy related if the recorded major diagnostic category value was 14 (pregnancy, childbirth, and the puerperium), or International Classification of Diseases, 9th edition, Clinical Modification (ICD-9) V-codes of 22.*, 23.*, 24.*, 26.*, 27.*, 28.* were recorded and no ICD-9 diagnosis codes 633.*-639.* were recorded.
The BW value from the birth certificate was set to missing in cases where the value was ≥6800 g or <400 g for a live birth. Singleton cases with missing values were replaced with the median BW value for infants of the same gestational age at birth if there was a valid gestational age (n = 74). For gestational age, we used the best obstetric estimate of gestational age when it was available; the LMP gestational age was used for 2436 cases. The gestational age value from the birth certificate (or fetal death certificate) was set to missing in cases indicating a live birth at <22 weeks of gestation or a gestational age of >45 weeks. For survivors, 3317 infant records with a gestational age at discharge <34 weeks of gestation were removed as probable data errors.
ICD-9 procedure codes were used to identify infants who underwent surgical procedures using a procedure classification system developed by the Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project that classifies procedures as major or minor therapeutic or diagnostic procedures. 15 We performed a further review of major therapeutic surgical procedures to flag procedures likely having major costs associated with them (such as a major heart surgery). Flagging such cases was done to assist in the identification of infant cost outliers-big cases with high costs were retained rather than being classified as outliers.
The Office of Statewide Planning and Development annual hospital financial data for 2009-2011 were used to construct cost-to-charge ratios for each hospital and these ratios were used to convert hospital charges recorded in the maternal and infant hospital discharge records to estimated costs. 16 Data on the mean professional/physicians fees for each diagnosis related group and payer source (Medicaid or private insurance) were matched with the diagnosis related groups of each hospital discharge to incorporate estimated professional fees, with separate adjustment factors for Medicaid and private insurance. 17 Although these physician data are fees, not costs, we believe that they represent the best available method for adding an estimate of physician costs to our data. For simplicity, we use the term costs even when this refers to estimates derived from other sources. The Bureau of Labor Statistics producer price index (PPI) was used to adjust costs to December 2017 values. 18, 19 We excluded cases when the estimated costs were clearly inconsistent with the care that was provided. Maternal costs were flagged as data errors and set to missing if hospital costs-perday were <$500 or >$10 000, or if total hospital costs were <$1000. Neonatal costs were examined separately for survivors, nonsurvivors, and major surgical cases. One surgical case with a total hospital cost-per-day of <$125 was flagged as a data error and hospital costs were set to missing. For nonsurgical cases, for survivors, hospital costs were set to missing if hospital cost-per-day was less than the first percentile for gestational age, because this threshold represented the point at which the costs were clearly in error across all gestations. For survivors with a LOS of ≤5 days, observations with hospital costs per day of >$10 000 were capped at $10 000. For nonsurvivors with a LOS of 2-5 days with hospital costs per day of >$20 000, hospital costs per day were capped at $20 000.
The Figure ( available at www.jpeds.com) outlines how these criteria affected the study sample. Of the 1 562 901 inhospital deliveries, 1 499 769 (96%) were linked to both maternal and infant discharge abstracts. There were 6470 cases excluded owing to missing or excluded BW or gestational age. The main reason cases were excluded was missing hospital charge data, which eliminated 203 096 cases (>85% of the excluded cases). Of these, 98% were excluded because they included ≥1 stays at a hospital operated by the Kaiser Permanente health system, which does not report hospital charges. An additional 24 991 cases were excluded because either the maternal or infant costs were considered to be outliers relative to their disease state, as described elsewhere in this article. Cases were retained only if cost and LOS information were available for both the mother and infant (only maternal costs were required for the fetal deaths). The final sample included 1 265 212 retained cases.
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In addition to reporting the estimated costs, LOSs, and mortality for all infants, we report these by gestational age and BW groups. For gestational age, we used the following groups: <25, 25-27, 28-32, 32-36, 37-38, 39-41, and >41 weeks. We also provided summary groups for extremely preterm (<28 weeks), very preterm (<32 weeks), and any preterm (<37 weeks). For BW, we report on the following groups: <1000, <1500, 1000-1499, 1500-2499, <2500, and ≥2500. For each of the tables reported in the results, there is a corresponding table available online that reports by week of gestational age and narrower BW intervals. Table I reports the number of maternal cases, live births, number of the live births that were multiple births, the number of fetal and infant deaths, and the mean maternal and infant LOS for all cases and for each of the gestational age and BW groups described (see Table II [available at www.jpeds.com] for more detailed data). For LOS, we also report the standard deviation, median, and IQR. The final sample includes 1 245 622 deliveries (includes fetal deaths), 1 260 457 live births, and 4755 fetal deaths. There were 19 280 maternal deliveries and 37 649 live births that were from a multiple delivery. The deaths are predominately preterm (77.7%), with 60.4% of the deaths being very preterm and one-half (50.1%) being extremely preterm. Table III reports the newborn costs until hospital discharge; these data are reported for all infants, including multiple births, by gestational age and BW (see Table IV [available at www.jpeds.com] for more detailed data). The mean and median costs per case declined dramatically as gestational age and BW increase, from a mean total cost of $350 000 for the smallest infants to about $2500 for term infants. In aggregate, the 8.1% of the live births that are preterm (<37 weeks) incur 60.9% of all newborn costs. Of these, the 1.0% who are very preterm (<32 weeks) incur 36.5% of all newborn costs, and the 0.4% who are extremely preterm (<28 weeks) incur 20.0% of newborn costs. This increase in the proportion of costs for each of these groups is modest compared with our data from 2000, when preterm infants, very preterm, and extremely preterm infants incurred 54%, 34%, and 19% of costs, respectively. 12 When the overall cost distribution is considered (data not shown) the results are even more skewed; the 1.2% of cases with costs of >$100 000 incur 51.0% of all infant costs. Conversely, 87.2% of the infants with costs of <$3000 incur only 15.8% of all newborn costs. We also provide this for survivors ( Table IX reports total maternal costs for all live births, which includes the costs of pregnancy-related prenatal hospitalizations (see Table X [available at www.jpeds.com] for more detailed data). The mean maternal costs for term deliveries were $7600-$7900. These costs were slightly higher for late preterm deliveries ($9600) and much higher for very preterm deliveries ($13 200-$23 300). The maternal costs are much less skewed than the infant costs; 76.5% of them were <$10 000 and these cases incurred 53.0% of all maternal costs. There were many fewer expensive cases and these cases had a much smaller share of total maternal costs; the 2.1% of the cases that exceeded $25 000 incurred 11.0% of costs. Table IX also provides separate information on the frequency and costs of pregnancyrelated prenatal hospitalizations. About 5.5% of the maternal cases had ≥1 pregnancy-related prenatal hospitalizations and the women who had such admissions averaged 1.2 admissions. These prenatal hospitalizations represent only those cases that were officially classified as a hospital admission and do not include those cases where a woman was observed on the obstetric ward for a few hours but not officially admitted to the hospital. Table XI (available at www.jpeds.com) includes the cases that results in a fetal death. Summary information about the differences in maternal costs by type of delivery are reported in Table XII (available at www.jpeds.com). As would be expected, maternal costs were markedly higher for cesarean deliveries; the mean cost was $11 006 vs $6754 for vaginal deliveries and these differences were greater for preterm deliveries.
Results
Table XIII provides data on how costs are split between hospitals and physicians by gestational age and BW (see Table XIV [available at www.jpeds.com] for more detailed data). For each cell, we report the number of cases and mean hospital and physician costs separately for mothers and infants. Overall, physician costs are 31% of total costs for mothers and 18% of the total costs for newborns. The physician's share of total costs is almost unchanged as gestational age changes for both mothers and infants; the infant physician share increases to 29% for extremely preterm cases, and the maternal physician share decreases to 29% for these cases.
Table XV (available at www.jpeds.com) reports the combined maternal and infant costs.
Discussion
These data provide a population-based update to the birth hospitalization costs and days of care for mothers and neonates. These cost estimates also include physician costs, which have been lacking in most previous studies. Maternal and especially newborn costs are sensitive to gestational age and BW, with the highest average costs accruing for infants born with a gestational age <28 weeks and for mothers delivering between 28 and 36 weeks of gestation. Newborn costs, especially those for the most preterm infants, are also sensitive to changes in survival. Compared with prior work, 12 the increase in survival among premature infants is the driver behind the 7% increase in the share of infant costs incurred by preterm infants.
Our data show how the costs for maternity and neonatal care have increased in the 10 years since we previously reported these population-based costs for California. 12 The mean maternal cost increased from $3641 to $8204 and the mean infant cost increased from $3567 to $6389. Our previous estimates did not include estimated physician reimbursement; if physician fees are excluded, the mean maternal cost is $5660 (55% increase) and the mean newborn cost is $5239 (47% increase). Adjusting for inflation, these cost increases are modest; 10.3% for maternal delivery hospitalizations and 4.3% for neonatal hospitalization costs. 18 Some of the increase in maternal costs is likely associated with the increased rate of cesarean deliveries (mean difference of $4550; Table XII), which has reversed in more recent years. 20 These differences help to highlight why it is important to periodically update the estimates of the costs of maternal and infant care to account for changes in survival and clinical practice.
Although the overall newborn costs have been essentially constant, those for the smallest infants have increased; after adjustment for physician fees and inflation, the costs for very preterm infants increased by 92.4%. Some of this increase can be attributed to the fact the survival roughly doubled for these smallest infants and the difference is sensitive to gestational age; at the lowest gestational age, the average cost for a survivor is hundreds of thousands more than for nonsurvivors ( Table V and Table VI) . But because the mean LOS for these infants only increased by about 10 days, the increased survival does not account for all, or even most, of the 90% increase in costs for these infants. Although our analyses are not designed to identify the causes, this implies that these infants have become significantly more expensive to treat, both overall, and in cost per day. Additional analyses are needed to understand why very preterm infants have become so much more expensive to treat.
The maternal data highlight some important public health trends in maternal child health. First, operative mode of delivery increases the costs of childbirth by 63%, with even greater increases seen in women who deliver prematurely. These costs are secondary to both physician fees, which are increased for operative deliveries, and for the longer LOSs typically seen in women who deliver via cesarean delivery. With growing evidence that many of these deliveries may be occurring in lowrisk women, 5,21 the baseline added costs of these deliveries are a concerning trend in maternity care. Second, we found significant economic impact of the women who deliver moderately and late preterm, with similar LOSs for women who deliver at 32-36 weeks of gestation to those who deliver at 24 weeks of gestation or less, and greater overall costs of care.
Neonatal data differ from maternal data in the importance of the outlier patients: for neonates, the 1.2% of infants whose costs were >$100 000 made up 51% of the economic impact of newborn care, whereas the 2.1% of women whose costs were >$25 000 only made up 11% of the maternal costs. These infants are the sickest, smallest infants whose LOSs, medical requirements, and transfers of care within the medical system are the greatest and provide an area of intervention to decrease the economic costs of neonatal care.
There are limitations to our data. They are from California, where hospital costs are higher than the US average. Care patterns and costs could be different in other parts of the country. In 2014, average US hospital costs were 69% of those in California, 22 which can be used as the basis of adjusting our results to obtain estimates of the national average costs for delivery care. 22 When considering aggregate costs, one also needs to consider that preterm rates in California are lower than the national average. Thus, using these data to project national costs would require adjustments for the differences in the gestational age distribution.
There are some limitations to the estimated costs in our study because we did not directly observe either physician or hospital costs. First, the hospital and physician costs are not fully equivalent. The hospital costs are estimated by converting hospital charges to estimated costs using hospital-level cost-to- charge ratios; physician costs are estimated by the average payments to physicians, measured separately for privately insurance and Medicaid. In addition to not being equivalent, each of these methods of estimating costs has limitations. For hospital costs, it is possible that these ratios do not reflect the actual difference between costs and charges for care provided in neonatal and obstetric units. However, these methods have been used for estimating neonatal and obstetric unit hospital costs in prior work. There is no way to know the extent that this method may bias the estimates, but we expect that any bias will be moderate. For physician costs, we are making the assumption that the actual physician revenue is a reasonable proxy for costs. Our results are also sensitive to the choice of index to adjust for inflation, but there is no "perfect" index to adjust hospital costs for inflation. 19 It has been demonstrated that the medical component of the consumer price index significantly overstates actual medical care inflation. Because the results of our analysis are the production costs of care for mothers and neonates, a PPI is more consistent with our intent. PPIs also have limitations because they are based on revenue to producers and there are significant disconnects between revenue and production costs for hospitals, which vary greatly across different types of insurance. Although the Bureau of Labor Statistics recently started reporting separate hospital PPIs for different types of insurance, these data do not extend back to 2000, which would preclude the comparisons that we make with our previous work. Table XVI (available at www.jpeds.com) shows how the different measures would affect the inflation adjustments for 2010-2017 and 1999-2017. In general, with the exception of the medical component of the consumer price index, the effect of the choice of index on the inflation adjustment is small. Of note, there is no consistency over which measure has the higher inflation adjustment; for example, the overall PPI has a larger inflation adjustment than the Hospital Services PPI for 1999-2017, but a lower adjustment for 2010-2017.
The exclusion of all Kaiser cases owing to a lack of cost information is also a potential source of bias, because these cases are predominantly patients with private insurance. However, the share of patients with private insurance is still large (48%) and the net effect of this exclusion is modest; if all of the Kaiser cases had been included, privately insured patients would make up 54% of the sample.
Our exclusion of infant readmissions does result in the exclusion of some costs that could be considered related to delivery. Although the greatest volume of these cases is probably related to neonatal jaundice, the impact of excluding the jaundice cases should be moderate, given their relatively low cost. 23 Conversely, there are cases of readmission incurring much higher costs, such as infants readmitted for major cardiac surgery. Also, the sickest infants born at the youngest gestational ages have the highest risk of a hospital readmission, which adds to the economic burden of these high severity patients. 24 In conclusion, our data demonstrate that maternal and infant costs are sensitive to the timing of delivery, the mode of delivery, and changes in survival, especially for the sickest of infants. Even with these increasing costs, neonatal intensive care remains a highly cost-effective intervention when compared with other interventions. [25] [26] [27] Such data highlight the persistent economic impact of childbirth in the US and areas for further intervention in the face of ongoing changes in survival and technology. ■ Retained 1 499 769 records that were linked to both maternal and infant discharge abstracts for live births or maternal discharge abstract for fetal deaths.
Figure.
Derivation of the study sample.
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